MyAverix Finance
SHG · Healthcare
Chemclin Diagnostics Co. Ltd. A (688468)
Diagnostics & Research
Chemclin Diagnostics Co. Ltd. A (688468) is listed on SHG in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $2.94B, P/E ratio is 52.36, net margin is 16.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688468
Chemclin Diagnostics Co. Ltd. A (688468) — FAQ
What is Chemclin Diagnostics Co. Ltd. A's market cap?
Chemclin Diagnostics Co. Ltd. A (688468) has a reported market cap of $2.94B (data as of 2026-03-29).
What is 688468's P/E ratio?
The price-to-earnings (P/E) ratio for Chemclin Diagnostics Co. Ltd. A (688468) is 52.36 (data as of 2026-03-29).
Does Chemclin Diagnostics Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Chemclin Diagnostics Co. Ltd. A (688468). Check the MyAverix Finance app for the latest dividend data.
What sector is Chemclin Diagnostics Co. Ltd. A in?
Chemclin Diagnostics Co. Ltd. A (688468) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 688468 listed on?
688468 is listed on SHG.
What is Chemclin Diagnostics Co. Ltd. A's net margin?
Chemclin Diagnostics Co. Ltd. A (688468) reports a net margin of 16.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.